Literature DB >> 3651306

Comparative clinical and laboratory features of legionella with pneumococcal and mycoplasma pneumonias.

M A Woodhead1, J T Macfarlane.   

Abstract

The clinical and laboratory features of 83 cases of community-acquired pneumococcal pneumonia (PP), 79 cases of legionella pneumonia (LP) and 62 cases of mycoplasma pneumonia (MP) have been compared. No unique features have been found in any group. Patients with MP were younger, were more likely to have had prior antibiotics before hospital referral, had a predominance of upper respiratory tract symptoms, low total white cell counts and lacked features of multisystem involvement. Multisystem features were common in both PP and LP with confusion, high fever, hyponatraemia, hypoalbuminaemia and abnormalities of liver function occurring more often in LP. A high leucocyte count was especially common in PP. Antibiotic therapy in community-acquired pneumonia must remain empirical until a definite microbiological diagnosis is made.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3651306     DOI: 10.1016/0007-0971(87)90130-6

Source DB:  PubMed          Journal:  Br J Dis Chest        ISSN: 0007-0971


  17 in total

1.  Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital.

Authors:  R Bohte; R van Furth; P J van den Broek
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

2.  Quality of published reports of the prognosis of community-acquired pneumonia.

Authors:  C A Carson; M J Fine; M A Smith; L A Weissfeld; J T Huber; W N Kapoor
Journal:  J Gen Intern Med       Date:  1994-01       Impact factor: 5.128

3.  Radiographic features of staphylococcal pneumonia in adults and children.

Authors:  J Macfarlane; D Rose
Journal:  Thorax       Date:  1996-05       Impact factor: 9.139

4.  A predictive model for the treatment approach to community-acquired pneumonia in patients needing ICU admission.

Authors:  P M Olaechea; J M Quintana; M S Gallardo; J Insausti; E Maraví; B Alvarez
Journal:  Intensive Care Med       Date:  1996-12       Impact factor: 17.440

5.  Community acquired pneumonia: aetiology and usefulness of severity criteria on admission.

Authors:  A M Neill; I R Martin; R Weir; R Anderson; A Chereshsky; M J Epton; R Jackson; M Schousboe; C Frampton; S Hutton; S T Chambers; G I Town
Journal:  Thorax       Date:  1996-10       Impact factor: 9.139

6.  Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee.

Authors:  B M Farr; D L Kaiser; B D Harrison; C K Connolly
Journal:  Thorax       Date:  1989-12       Impact factor: 9.139

Review 7.  Treatment of Legionnaires' disease. Current recommendations.

Authors:  J Roig; A Carreres; C Domingo
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

8.  Opportunist pulmonary infection with Legionella bozemanii.

Authors:  C R Swinburn; F K Gould; P A Corris; T L Hooper; N J Odom; R Freeman; C G McGregor
Journal:  Thorax       Date:  1989-05       Impact factor: 9.139

9.  Algorithm to determine cost savings of targeting antimicrobial therapy based on results of rapid diagnostic testing.

Authors:  J J Oosterheert; M J M Bonten; E Buskens; M M E Schneider; I M Hoepelman
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

10.  Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ).

Authors:  Heike von Baum; Tobias Welte; Reinhard Marre; Norbert Suttorp; Christian Lück; Santiago Ewig
Journal:  BMC Infect Dis       Date:  2009-05-13       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.